BIM.PA PAR
bioMérieux S.A.
1W: -1.2%
1M: +1.1%
3M: +8.8%
YTD: -18.6%
1Y: -35.3%
3Y: -15.8%
5Y: -27.1%
€76.75 ($85.87)
-0.45 (-0.58%)
Weekly Expected Move ±3.3%
€72
€74
€77
€79
€82
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$4.1B
+2.3% ▲
5Y CAGR: +5.5%
Gross Profit
$2.1B
-3.3% ▼
5Y CAGR: +4.3%
Operating Income
$561M
-4.7% ▼
5Y CAGR: +0.4%
Net Income
$398M
-8.0% ▼
5Y CAGR: -0.3%
EPS (Diluted)
$3.34
-8.2% ▼
5Y CAGR: -0.4%
EBITDA
$1000M
+11.4% ▲
5Y CAGR: +6.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.4B | $3.6B | $3.7B | $4.0B | $4.1B |
| YoY Growth | +8.3% | +6.3% | +2.4% | +8.3% | +2.3% |
| Cost of Revenue | $1.4B | $1.6B | $1.6B | $1.8B | $1.9B |
| Gross Profit | $2.0B | $2.0B | $2.1B | $2.2B | $2.1B |
| Gross Margin | 58.3% | 54.6% | 56.0% | 55.7% | 52.6% |
| R&D Expenses | $386M | $447M | $460M | $492M | $507M |
| SG&A Expenses | $816M | $955M | $1.0B | $1.1B | $1.1B |
| Operating Expenses | $1.2B | $1.4B | $1.6B | $1.6B | $1.6B |
| Operating Income | $768M | $560M | $439M | $589M | $561M |
| Operating Margin | 22.7% | 15.6% | 11.9% | 14.8% | 13.8% |
| Interest Expense | $9M | $4M | $4M | $16M | $0 |
| Income Before Tax | $748M | $550M | $438M | $579M | $526M |
| Tax Expense | $149M | $110M | $114M | $154M | $129M |
| Net Income | $601M | $452M | $358M | $432M | $398M |
| Net Margin | 17.8% | 12.6% | 9.7% | 10.9% | 9.8% |
| EPS (Diluted) | $5.06 | $3.82 | $3.01 | $3.64 | $3.34 |
| EBITDA | $978M | $812M | $701M | $898M | $1000M |
| Shares Outstanding | 119M | 118M | 119M | 119M | 119M |